VSee Health, Inc. Stock Price, News & Analysis

VSee Health (NASDAQ:VSEE) announced progress executing contracts through its iDoc telemedicine platform on November 25, 2025. Key execution items: two new hospitals are live and are conservatively projected to generate $500,000 in annual revenue; 21 of 34 hospitals in its Health network are activated with 7 more slated for Q1 2026; four new teleradiology hospitals were activated recently; and one Large Regional Leading Hospital partnership targets a Jan/Feb 2026 launch for virtual urgent care and behavioral health. VSee said it has submitted proposals for two new hospital contracts with a combined potential value of $3 million if awarded. The company emphasized scaling teleradiology, telenursing, and telehealth services to convert contracted deals into recurring revenue.

VSee Health (Nasdaq:VSEE) named Dr. Milton Chen as chairman of the board on November 20, 2025.

Dr. Chen cofounded VSee, wrote the first VSee software as a Stanford PhD student, and has defined the company's no-code, low-code AI infrastructure strategy. The announcement says VSee's building blocks help connect AI modules to hospitals by providing EMR integration, event queueing, and security.

Management highlights include Dr. Chen's 15+ years of AI telehealth product development and board leadership, and prior deployments of VSee for public figures cited as examples of company use.

VSEE Health (Nasdaq:VSEE) reported Q3 2025 total revenues of $3.98M, a 19% YoY increase, and YTD revenues of $10.69M, up 60% YoY. Gross margin remained ~52%. Telehealth fees rose 196% YoY to $1.44M and patient fees increased 42% to $0.88M. Cash used in operations improved to $1.52M for nine months (46% better YoY) while cash on hand was $472,759. Company cited full activation of a $10M+ teleradiology deal (100,000+ reads) and achieving FedRAMP High status. Balance sheet shows total assets of $18.71M and total current liabilities of $23.42M, with an accumulated deficit of $74.57M.

VSee Health (Nasdaq:VSEE) announced FedRAMP Moderate authorization and integration of ICU robotic assistance to enable remote clinician monitoring and intervention in intensive care units. The company reported a 150% year-over-year increase in enterprise deployments and cited recent contract wins, including an agreement to expand public mental health services in a large U.S. county. VSee highlighted platform features like omni-channel visits and EHR integrations and said pipeline partnerships could add millions in recurring revenue by Q2 2026. The release cites a U.S. telehealth market projection of $52.76 billion in 2025 with a 23.84% CAGR through 2034.

VSee Health (NASDAQ:VSEE) met with Philippine Tuberculosis Society and former vice president Leni Robredo (mayor of Naga City) on November 6, 2025 to explore digital health collaborations in Naga City focused on maternal health, primary care and TB testing.

Discussion highlighted Naga City gaps such as a 44% prenatal check-up rate versus the Department of Health target of 99%, use of mobile healthcare caravans, and PhilHealth's YAKAP subsidy of ₱1,700 (USD 29) per qualified patient for full primary care delivery. The release cites Southeast Asia digital health market size estimates of USD 17B (2024) growing to USD 38.8B by 2033, and the Philippines reaching USD 1B by 2027.

VSee noted ongoing Philippines projects (Project MAMA maternal health, TB screenings with Remedi and iOne Resource) as context for potential expansion and partnership-building in the region.

VSee Health (NASDAQ:VSEE) executed a three-year platform services agreement to provide virtual urgent care and virtual behavioral health across a health system operating more than 100 hospitals, outpatient centers, and affiliated sites. The contract is volume-based and invoice-only with no upper limit on reimbursable services, linking revenue directly to utilization. Services commence January 1, 2026. The unnamed partner is the region's sole Level 1 Trauma Center and an academic health system with longstanding medical school affiliation and multiple national rankings, which VSee characterizes as a national blueprint for replication to other top-tier academic and safety-net systems.

VSee Health (Nasdaq:VSEE) reports rapid teleradiology expansion after a FedRAMP High approval on October 28, 2025. The company says it completed 100,000+ radiology reads in six months across 18 of 35 hospitals, with full rollout to the remaining sites by December 31.

Reported operational and financial highlights include a Q2 revenue jump of 98% YoY to $3.4M with 47% margins, a disclosed $10M+ Level 1 hospital contract, a stated 285% stock surge since the FedRAMP milestone, and claimed access to a $455B federal telehealth opportunity through 2030.

VSee (Nasdaq:VSEE) announced it received an Authority to Operate (ATO) at the FedRAMP High level from the U.S. Department of Health and Human Services on October 28, 2025. The authorization permits other federal agencies to use VSee where FedRAMP High is required.

The platform is positioned for secure telehealth with enterprise encryption, HIPAA compliance, HIE interoperability, hybrid workflows, and rapid multi-site activation. In July, VSee rapidly deployed a secure telemedicine bridge for HHS ASPR to keep the only hospital on St. Croix operational after a cyberattack, clearing over 250 backlogged radiology studies within days. VSee is also advancing AIMEE, a rural hospital transformation initiative.

VSee Health (NASDAQ:VSEE) announced record-setting revenue growth and the elimination of over $5 million in legacy SPAC debt on October 23, 2025. The company said this debt removal strengthens its balance sheet, bolsters creditor confidence, and helps ensure compliance with NASDAQ listing requirements. Management framed the move as positioning VSee Health for sustained long-term growth and noted shareholder support as a key factor in the milestone.